VRTX · أرشيف الأبحاث الشهرية

VRTX May 2026 · strong-buy

Vertex is a highly profitable, mature compounder with a dominant franchise in cystic fibrosis generating massive free cash flow. The next phase of growth relies on successfully commercializing its pipeline, including CASGEVY for sickle cell disease and novel pain treatments.